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Abstract
Background: The Two-Week Rule (TWR) was introduced to ensure that all patients with a
suspected colorectal cancer (CRC) saw a hospital specialist within 14 days of an urgent GP referral.
Guidelines were available to GPs to facilitate the appropriate TWR referral of patients exhibiting
high-risk CRC symptoms.
Methods: We aimed to evaluate the TWR and its CRC detection rate on NHS CRC diagnostic
services by performing a literature search and critically appraising the peer-reviewed studies. Only
12 studies were eligible for inclusion. Data was collected and overall results were given as weighted
averages.
Results: The studies identified indicated that only 10.3% of patients referred by the TWR were
eventually diagnosed with CRC. When examining the referral origin of all CRC patients diagnosed
during the time of the studies, 24% had been referred using the TWR, 24.1% were referred as
emergency cases, and 52.4% were referred using alternative routes. No evidence was found to
indicate that the TWR had resulted in identifying CRC patients at an earlier, more treatable stage
of their disease.
Conclusion: The TWR referral system needs to be improved to increase the number of CRC
patients referred using this fast track method as they present to their GP. The TWR and new NICE
Guidelines for the referral of patients with suspected cancer should be independently evaluated.
Background
The Government set targets to be achieved by 2000 for
NHS Trusts in England and Wales to see patients with sus-
pected cancer within two weeks of an urgent referral by
their GP [1], where "suspected" was defined as either a
perceived level of probability or a hunch [2]. This was
achieved by the implementation of the Two-Week Rule
(TWR) for fast tracking suspected cancer referrals from pri-
mary to secondary care [3].
To facilitate the appropriate use of the TWR, Guidelines
were published by the Department of Health (DoH)
detailing the high-risk criteria exhibited by patients with
suspected cancer [4]. In the case of colorectal cancer
(CRC), the Guidelines' list of high-risk symptoms aimed
to "identify up to 90 per cent of patients with bowel can-
cer" to be urgently referred using the TWR. The Guidelines
recommended that a patient needed to exhibit a combina-
tion of the high-risk symptoms to be appropriately
referred using the TWR. Patients referred using the TWR
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considered inappropriate referrals.
Since 2000, English NHS Trusts have reported their com-
pliance with the TWR to the DoH on a quarterly basis. The
report for the first Quarter of 2005/06 showed that 99.5%
of all patients referred with a suspected lower gastrointes-
tinal cancer via the TWR were seen within two weeks [5].
A recent publication by Chohan et al highlighted the suc-
cess of the TWR in speeding up patients' access to clinics
at their hospital but reported a low CRC detection rate of
27%. The CRC patients diagnosed via this route also
tended to have more advanced stage of the disease [6].
In light of this, we performed a literature search to evalu-
ate all peer-reviewed evidence reporting on the TWR and
its CRC detection rate within NHS CRC diagnostic services
to determine whether the TWR was effective in identifying
suspected CRC patients, and whether they were diagnosed
at an earlier stage of their disease.
Methods
A literature search was performed using Medline, the
Cochrane Library, the National Library for Health (NLH),
the Health Management Information Consortium
(HMIC) and the Centre for Reviews and Dissemination
(CRD), employing a text search for peer-reviewed research
publications. The search terms used were "colorectal" or
"CRC" in combination with "urgent referral*", "two
week*", "2-week*" and "fourteen day*".
Studies performed outside England and Wales were
excluded, as were studies performed prior to the imple-
mentation of the TWR in July 2000 or in non-NHS organ-
isations. Only peer-reviewed studies commenting on the
effectiveness of the TWR in NHS CRC diagnostic services
were selected based on the abstract by one author (KT).
Data describing the TWR CRC detection rate and the refer-
ral routes of CRC patients identified during the study were
extracted, as well as any reports on the stage of the disease
in CRC patients. Data extracted were actual values. All
studies with comparable datasets were combined to give
overall results, given as weighted averages.
Results
During the initial search for literature, a total of 123 arti-
cles were retrieved. Of these, 103 were immediately
excluded because they did not refer to TWR in any way. Of
the remaining 20 articles, one did not relate directly to
TWR efficiency, four studies were done prior to the official
implementation on TWR in July 2000 and three were let-
ters. This left 12 articles suitable for inclusion. Of these,
only eight had comparable data reporting on the effect of
the TWR in NHS CRC diagnostic services. These studies
consisted of two retrospective studies and six prospective
studies, four of which were based on audits (see Table 1).
These studies were performed between 2000 and 2003.
The studies identified showed that of the 2440 patients
referred by their GP using the TWR, only 10.3 per cent
were subsequently diagnosed with CRC (see Table 2).
When determining the referral route of all CRC patients
diagnosed during the time of the studies identified, we
found that only 24 per cent of CRC patients were referred
by GPs using the TWR, [6-13] with a further 24.1 per cent
being referred as emergency cases [6-8,11-13]. The
remaining 52.4 per cent had been referred by other routes
(see Table 2) [6-8,11-13]. For two studies, [9,10] the
number of emergency cases could not be extracted from
the non-TWR referrals and were not included in the sum-
mary values above.
Although most patients were seen by a hospital specialist
within the two-week target, no studies reported any signif-
icant difference in the stage of the disease of CRC patients
referred and diagnosed using the TWR compared with
other referral routes [6,8,11,14].
Of the four articles retrieved in the literature search but
not included in Table 1, one was a systematic review of
cancer waiting time audits [15] commissioned by the
Table 1: Description of the studies used in this paper.
First author & Reference Location of study Study Type Time period studied
Chohan [6] Addenbrookes Hospital, Cambridge Retrospective observational study Jul 2000 to Dec 2001
Maruthachalam [7] Newcastle upon Tyne NHS Trust Prospective evaluative study Jan to Dec 2003
Eccersley [8] Luton & Dunstable NHS Trust Prospective audit Jan 2000 to March 2001
Walsh [9] Blackpool Victoria Hospital, Blackpool Prospective audit Aug to Oct 2000
Debnath [10] South Durham Healthcare Trust Prospective audit Aug 2000 to Jul 2001
Flashman [11] Queen Alexandra Hospital, Portsmouth Prospective audit Jul 2000 to Jun 2001
Barwick [12] St James' University Hospital, Leeds Retrospective observational study Jan to Aug 2001
Tricket [13] Ashford & St Peter's Hospital NHS Trust Prospective observational study † Nov 2000 to Oct 2001
Key: † Study looked at CRC patients onlyPage 2 of 5
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lished by the CRD. This review identified a total of 39 hos-
pital audits relating to lower GI cancer. From these, the
review reported that the CRC detection rate for the TWR
ranged from 2 – 22 per cent and that between 0 – 47 per
cent of CRC patients were referred using the TWR.
The remaining three studies retrieved by the literature
search included a qualitative assessment of the DoH
Guidelines, [14] one focussed on the impact of a fast track
barium enema service, [17] and one reported on varia-
tions in the evaluation of CRC risk [18].
Discussion
Although the DoH Guidelines aimed to identify 90 per
cent of CRC patients as they presented to their GP, the lit-
erature identified by this paper indicated that only 10.3
per cent were eventually diagnosed with CRC. This figure
is based on the assumption that all TWR referrals were
appropriate. Less than a quarter of all CRC patients had
been referred using the TWR, the same proportion had
been referred as emergency cases and just over half of all
CRC patients diagnosed during the time of the studies had
been referred using alternative routes. There was no evi-
dence to indicate any significant improvement in detect-
ing CRC at an earlier stage in CRC patients referred using
the TWR compared to those referred by alternative routes.
This paper reviewed all relevant peer-reviewed evidence
from studies performed after 2000 reporting on the
impact of the TWR. There was a limited amount of peer-
reviewed literature in this field, with only 12 publications
meeting our inclusion criteria, and only eight of these
reporting comparable datasets. A single researcher
assessed the literature, but the tight focus on the inclusion
and exclusion criteria should have reduced any bias in the
selection of eligible studies. As far as we are aware, no
other evaluation of the literature in this field has been per-
formed to date.
Our assessment of the guidelines was based on calculating
the percentage of TWR-referred patients eventually diag-
nosed with CRC from all the studies and determining a
weighted average. We also compared the proportion of
CRC patients referred by the TWR compared with alterna-
tive routes into secondary care using weighted averages
calculated from the original papers.
The low number of CRC patients identified following a
TWR referral suggests that the Guidelines were not as
effective in identifying CRC patients as they presented to
their GP as was hoped. This may be explained by GPs
referring patients who did not conform to the Guidelines,
possibly due to the incorrect interpretation of the Guide-
lines or to intentionally speed up diagnoses in low-risk
patients where the routine waiting list was too long.
The studies identified reported that the proportion of CRC
patients diagnosed by alternative routes (excluding emer-
gencies) was more than double those referred using the
TWR. These patients may not have exhibited any of the
high-risk symptoms specified by the Guidelines, or they
may have been internally referred following radiological
or pathological investigations from within secondary care,
where the TWR cannot be applied. Alternatively, it may be
the result of the referral practices of GPs [19]. These high
numbers of non-TWR referrals are cause for concern and
the TWR referral methodology may need to be changed to
capture these CRC patients.
Almost a quarter of all CRC patients were diagnosed fol-
lowing an emergency referral, although we were unable to
determine whether the source of their referral was primary
or secondary care. The majority of CRC patients diag-
Table 2: Data from eight peer-reviewed studies describing the effect of the TWR on their colorectal services.
First author
 & Reference
N° TWR
 referrals 
received
(i) % of CRCs identified
 from TWR referrals (n) 
Total number of 
CRC
 cases diagnosed †
Total % of CRC cases
 referred as...
TWR Emergency Other
Chohan [6] 462 13.8% (64) 195 32.8% 20% 47.2%
Maruthachalam [7] 639 8% (51) 234 21.8% 10.6% 67.6%
Eccersley [8] 180 14.4% (26) 145 18% 17% 66%
Walsh [9] 78 10.3% (8) 23 47.8% 52.2%
Debnath [10] 237 8.9% (21) 96 21.9% 78.1%
Flashman [11] 695 9.4% (65) 249 26.1% 35.3% 38.6%
Barwick [12] 149 10% (14) 84 16.7% 41.7% 41.7%
Tricket [13] NA NA 147 20% 29% 51%
Weighted averages of all 
values combined
10.3% 24% 24.1% 52.4%
Key: NA = Data not available in article; † = Total number of CRC cases diagnosed during the time of the study in the same locality.Page 3 of 5
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onto the TWR route if they presented with "emergency"
symptoms in need of immediate treatment, especially if
they presented to A&E instead of their GP.
The TWR did not result in CRC patients being diagnosed
at an earlier, more treatable stage of their disease. This
could be because patients correctly referred using the TWR
Guidelines need to exhibit high-risk symptoms indicative
of later stage CRC, whilst early stage CRC patients may not
have any alarm symptoms and may have been referred
using alternative routes.
Although CRC lacks any highly specific symptoms [12],
Selvachandran et al have successfully used a patient ques-
tionnaire to prioritise CRC referrals [20]. The studies iden-
tified in this review have shown that compiling highly
specific Guidelines for symptomatic CRC patients using
TWR referrals without compromising on their ability to
detect early CRC can be problematic [8,10,13,14]. A liter-
ature search performed by Hamilton and Sharp concluded
that the DoH Guidelines were based on a reasonable evi-
dence base [21] but the studies identified for this paper
indicate otherwise, although it is worth noting that TWR
referrals were assumed to be appropriate in accordance
with the Guidelines. Research into the positive predictive
value of CRC symptoms in the UK population is ongoing
[22] to improve the sensitivity and specificity of the
Guidelines, although the revised TWR referral Guidelines
by NICE [16], published in 2005, are almost identical to
the original DoH Guidelines and so, are not likely to
increase the proportion of CRC patients diagnosed using
the TWR.
The TWR was rapidly implemented throughout NHS can-
cer diagnostic services with no pilot studies done to indi-
cate potential problems. Both primary and secondary care
services had to cope with the new referral protocols and
their subsequent impact on services. We would question
whether the TWR has had any positive effect on the iden-
tification of CRC patients at an earlier stage of their dis-
ease. To address this, we recommend that the TWR and
the revised NICE Guidelines should be officially evaluated
by an independent group to determine whether there is
any subsequent increase in the identification of CRC
patients, accompanied by an improvement in the cancer
stage at diagnosis to make the TWR worthwhile. A small
scale evaluation has already been successfully established
[23] and could be used as a basis for a nationwide study.
We also recommend that the new NICE Guidelines be
made compulsory for all GPs and that TWR referral docu-
mentation is standardised so that comparisons can be
made during any evaluations.
Conclusion
The evidence presented in this paper indicates that the
detection rate for TWR-referred CRC was low and approx-
imately half of all CRC patients are referred by alternative
routes prior to their diagnosis. Although most patients
were seen by a hospital specialist within two weeks of
referral, the TWR did not result in the identification of
CRC patients at an earlier stage of their disease. We con-
clude that the TWR referral system is in need of improve-
ment and independent evaluation.
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